Einstein (São Paulo) (Sep 2011)

Prevention of thromboembolic events in patients with atrial fibrillation – new anticoagulants

  • Alexandre Holthausen Campos,
  • Cláudio Cirenza

DOI
https://doi.org/10.1590/s1679-45082011md2276
Journal volume & issue
Vol. 9, no. 3
pp. 409 – 411

Abstract

Read online Read online

ABSTRACT The authors present alternatives for the treatment of cardiac arrhythmias. Its detection is based on the use of different methods that record the cardiac electrical activity. The treatment involves intervening in the underlying disorder, antiarrhythmic drugs, stimulation and cardiac defibrillation devices, and, less often, surgery. The technological advances in the last two decades have provided greater efficiency in diagnoses and therapy. Atrial fibrilation patients will benefit from a new set of anticoagulant drugs tested in the past three years. The potential advantages include greater safety and efficacy, as well as convenience for not requiring frequent laboratory controls.

Keywords